The global market for Pharmaceutical Peptides Services was valued at US$ 5727 million in the year 2024 and is projected to reach a revised size of US$ 9495 million by 2031, growing at a CAGR of 7.6% during the forecast period.

Pharmaceutical Peptides Services Market

Pharmaceutical peptides services refer to the range of services offered by pharmaceutical companies or specialized service providers for the development, production, and analysis of peptides for therapeutic purposes. These services typically include:

1. Peptide synthesis: Custom synthesis of peptides based on specific requirements, including the design and production of peptide libraries.

2. Peptide modification: Chemical modification of peptides to enhance their stability, bioavailability, or target specificity.

3. Peptide purification: Purification of synthesized peptides to remove impurities and obtain high-quality products.

4. Peptide characterization: Comprehensive analysis of peptides using techniques such as mass spectrometry, high-performance liquid chromatography (HPLC), and nuclear magnetic resonance (NMR) spectroscopy to determine their identity, purity, and structural properties.

5. Peptide formulation: Development of peptide formulations suitable for various administration routes, such as oral, injectable, or topical delivery.

6. Peptide stability studies: Evaluation of the stability of peptides under different conditions, including temperature, pH, and storage conditions, to ensure their shelf-life and efficacy.

7. Peptide bioassays: Testing the biological activity and efficacy of peptides using in vitro and in vivo models to assess their therapeutic potential.

8. Peptide scale-up: Scaling up the production of peptides from laboratory-scale to commercial-scale manufacturing, ensuring consistent quality and quantity.

9. Regulatory support: Assistance in navigating regulatory requirements and guidelines for the development and approval of peptide-based therapeutics.

10. Contract research and manufacturing: Collaborative partnerships or outsourcing of peptide-related research, development, and manufacturing activities to specialized service providers.

These services are essential for the discovery, development, and production of peptide-based drugs, which have gained significant attention in the pharmaceutical industry due to their high specificity, low toxicity, and potential for targeting various diseases.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Peptides Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Peptides Services.

The Pharmaceutical Peptides Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Peptides Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pharmaceutical Peptides Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pharmaceutical Peptides Services Market Report

Report Metric	Details
Report Name	Pharmaceutical Peptides Services Market
Accounted market size in year	US$ 5727 million
Forecasted market size in 2031	US$ 9495 million
CAGR	7.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Peptide Drug Discovery Peptide Drug Bioconjugations Peptide Lead Optimization Formulation Development Peptide Drug Screening Service Total Peptide Library Construction Technology Other
Segment by Application	Enterprise Research Institute
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Creative Peptides, AmbioPharm, 3B Pharmaceuticals, ISSAR Pharma, Peptide Institute, WuXi AppTec, JPT Peptide Technologies, CPC Scientific, Red Glead Discovery, Eurofins Scientific, Bio-Synthesis, Bio Basic, CordenPharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Peptides Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Pharmaceutical Peptides Services Market growing?

Ans: The Pharmaceutical Peptides Services Market witnessing a CAGR of 7.6% during the forecast period 2025-2031.

What is the Pharmaceutical Peptides Services Market size in 2031?

Ans: The Pharmaceutical Peptides Services Market size in 2031 will be US$ 9495 million.

Who are the main players in the Pharmaceutical Peptides Services Market report?

Ans: The main players in the Pharmaceutical Peptides Services Market are Creative Peptides, AmbioPharm, 3B Pharmaceuticals, ISSAR Pharma, Peptide Institute, WuXi AppTec, JPT Peptide Technologies, CPC Scientific, Red Glead Discovery, Eurofins Scientific, Bio-Synthesis, Bio Basic, CordenPharma

What are the Application segmentation covered in the Pharmaceutical Peptides Services Market report?

Ans: The Applications covered in the Pharmaceutical Peptides Services Market report are Enterprise, Research Institute

What are the Type segmentation covered in the Pharmaceutical Peptides Services Market report?

Ans: The Types covered in the Pharmaceutical Peptides Services Market report are Peptide Drug Discovery, Peptide Drug Bioconjugations, Peptide Lead Optimization, Formulation Development, Peptide Drug Screening Service, Total Peptide Library Construction Technology, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pharmaceutical Peptides Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Peptide Drug Discovery

1.2.3 Peptide Drug Bioconjugations

1.2.4 Peptide Lead Optimization

1.2.5 Formulation Development

1.2.6 Peptide Drug Screening Service

1.2.7 Total Peptide Library Construction Technology

1.2.8 Other

1.3 Market by Application

1.3.1 Global Pharmaceutical Peptides Services Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Enterprise

1.3.3 Research Institute

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pharmaceutical Peptides Services Market Perspective (2020-2031)

2.2 Global Pharmaceutical Peptides Services Growth Trends by Region

2.2.1 Global Pharmaceutical Peptides Services Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Pharmaceutical Peptides Services Historic Market Size by Region (2020-2025)

2.2.3 Pharmaceutical Peptides Services Forecasted Market Size by Region (2026-2031)

2.3 Pharmaceutical Peptides Services Market Dynamics

2.3.1 Pharmaceutical Peptides Services Industry Trends

2.3.2 Pharmaceutical Peptides Services Market Drivers

2.3.3 Pharmaceutical Peptides Services Market Challenges

2.3.4 Pharmaceutical Peptides Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pharmaceutical Peptides Services Players by Revenue

3.1.1 Global Top Pharmaceutical Peptides Services Players by Revenue (2020-2025)

3.1.2 Global Pharmaceutical Peptides Services Revenue Market Share by Players (2020-2025)

3.2 Global Pharmaceutical Peptides Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Pharmaceutical Peptides Services Revenue

3.4 Global Pharmaceutical Peptides Services Market Concentration Ratio

3.4.1 Global Pharmaceutical Peptides Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Peptides Services Revenue in 2024

3.5 Global Key Players of Pharmaceutical Peptides Services Head office and Area Served

3.6 Global Key Players of Pharmaceutical Peptides Services, Product and Application

3.7 Global Key Players of Pharmaceutical Peptides Services, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutical Peptides Services Breakdown Data by Type

4.1 Global Pharmaceutical Peptides Services Historic Market Size by Type (2020-2025)

4.2 Global Pharmaceutical Peptides Services Forecasted Market Size by Type (2026-2031)

5 Pharmaceutical Peptides Services Breakdown Data by Application

5.1 Global Pharmaceutical Peptides Services Historic Market Size by Application (2020-2025)

5.2 Global Pharmaceutical Peptides Services Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Pharmaceutical Peptides Services Market Size (2020-2031)

6.2 North America Pharmaceutical Peptides Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Pharmaceutical Peptides Services Market Size by Country (2020-2025)

6.4 North America Pharmaceutical Peptides Services Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pharmaceutical Peptides Services Market Size (2020-2031)

7.2 Europe Pharmaceutical Peptides Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Pharmaceutical Peptides Services Market Size by Country (2020-2025)

7.4 Europe Pharmaceutical Peptides Services Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Pharmaceutical Peptides Services Market Size (2020-2031)

8.2 Asia-Pacific Pharmaceutical Peptides Services Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Pharmaceutical Peptides Services Market Size by Region (2020-2025)

8.4 Asia-Pacific Pharmaceutical Peptides Services Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Pharmaceutical Peptides Services Market Size (2020-2031)

9.2 Latin America Pharmaceutical Peptides Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Pharmaceutical Peptides Services Market Size by Country (2020-2025)

9.4 Latin America Pharmaceutical Peptides Services Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pharmaceutical Peptides Services Market Size (2020-2031)

10.2 Middle East & Africa Pharmaceutical Peptides Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Pharmaceutical Peptides Services Market Size by Country (2020-2025)

10.4 Middle East & Africa Pharmaceutical Peptides Services Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Creative Peptides

11.1.1 Creative Peptides Company Details

11.1.2 Creative Peptides Business Overview

11.1.3 Creative Peptides Pharmaceutical Peptides Services Introduction

11.1.4 Creative Peptides Revenue in Pharmaceutical Peptides Services Business (2020-2025)

11.1.5 Creative Peptides Recent Development

11.2 AmbioPharm

11.2.1 AmbioPharm Company Details

11.2.2 AmbioPharm Business Overview

11.2.3 AmbioPharm Pharmaceutical Peptides Services Introduction

11.2.4 AmbioPharm Revenue in Pharmaceutical Peptides Services Business (2020-2025)

11.2.5 AmbioPharm Recent Development

11.3 3B Pharmaceuticals

11.3.1 3B Pharmaceuticals Company Details

11.3.2 3B Pharmaceuticals Business Overview

11.3.3 3B Pharmaceuticals Pharmaceutical Peptides Services Introduction

11.3.4 3B Pharmaceuticals Revenue in Pharmaceutical Peptides Services Business (2020-2025)

11.3.5 3B Pharmaceuticals Recent Development

11.4 ISSAR Pharma

11.4.1 ISSAR Pharma Company Details

11.4.2 ISSAR Pharma Business Overview

11.4.3 ISSAR Pharma Pharmaceutical Peptides Services Introduction

11.4.4 ISSAR Pharma Revenue in Pharmaceutical Peptides Services Business (2020-2025)

11.4.5 ISSAR Pharma Recent Development

11.5 Peptide Institute

11.5.1 Peptide Institute Company Details

11.5.2 Peptide Institute Business Overview

11.5.3 Peptide Institute Pharmaceutical Peptides Services Introduction

11.5.4 Peptide Institute Revenue in Pharmaceutical Peptides Services Business (2020-2025)

11.5.5 Peptide Institute Recent Development

11.6 WuXi AppTec

11.6.1 WuXi AppTec Company Details

11.6.2 WuXi AppTec Business Overview

11.6.3 WuXi AppTec Pharmaceutical Peptides Services Introduction

11.6.4 WuXi AppTec Revenue in Pharmaceutical Peptides Services Business (2020-2025)

11.6.5 WuXi AppTec Recent Development

11.7 JPT Peptide Technologies

11.7.1 JPT Peptide Technologies Company Details

11.7.2 JPT Peptide Technologies Business Overview

11.7.3 JPT Peptide Technologies Pharmaceutical Peptides Services Introduction

11.7.4 JPT Peptide Technologies Revenue in Pharmaceutical Peptides Services Business (2020-2025)

11.7.5 JPT Peptide Technologies Recent Development

11.8 CPC Scientific

11.8.1 CPC Scientific Company Details

11.8.2 CPC Scientific Business Overview

11.8.3 CPC Scientific Pharmaceutical Peptides Services Introduction

11.8.4 CPC Scientific Revenue in Pharmaceutical Peptides Services Business (2020-2025)

11.8.5 CPC Scientific Recent Development

11.9 Red Glead Discovery

11.9.1 Red Glead Discovery Company Details

11.9.2 Red Glead Discovery Business Overview

11.9.3 Red Glead Discovery Pharmaceutical Peptides Services Introduction

11.9.4 Red Glead Discovery Revenue in Pharmaceutical Peptides Services Business (2020-2025)

11.9.5 Red Glead Discovery Recent Development

11.10 Eurofins Scientific

11.10.1 Eurofins Scientific Company Details

11.10.2 Eurofins Scientific Business Overview

11.10.3 Eurofins Scientific Pharmaceutical Peptides Services Introduction

11.10.4 Eurofins Scientific Revenue in Pharmaceutical Peptides Services Business (2020-2025)

11.10.5 Eurofins Scientific Recent Development

11.11 Bio-Synthesis

11.11.1 Bio-Synthesis Company Details

11.11.2 Bio-Synthesis Business Overview

11.11.3 Bio-Synthesis Pharmaceutical Peptides Services Introduction

11.11.4 Bio-Synthesis Revenue in Pharmaceutical Peptides Services Business (2020-2025)

11.11.5 Bio-Synthesis Recent Development

11.12 Bio Basic

11.12.1 Bio Basic Company Details

11.12.2 Bio Basic Business Overview

11.12.3 Bio Basic Pharmaceutical Peptides Services Introduction

11.12.4 Bio Basic Revenue in Pharmaceutical Peptides Services Business (2020-2025)

11.12.5 Bio Basic Recent Development

11.13 CordenPharma

11.13.1 CordenPharma Company Details

11.13.2 CordenPharma Business Overview

11.13.3 CordenPharma Pharmaceutical Peptides Services Introduction

11.13.4 CordenPharma Revenue in Pharmaceutical Peptides Services Business (2020-2025)

11.13.5 CordenPharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

JPT Peptide Technologies

List of Tables

Table 1. Global Pharmaceutical Peptides Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Peptide Drug Discovery

Table 3. Key Players of Peptide Drug Bioconjugations

Table 4. Key Players of Peptide Lead Optimization

Table 5. Key Players of Formulation Development

Table 6. Key Players of Peptide Drug Screening Service

Table 7. Key Players of Total Peptide Library Construction Technology

Table 8. Key Players of Other

Table 9. Global Pharmaceutical Peptides Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Pharmaceutical Peptides Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Pharmaceutical Peptides Services Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Pharmaceutical Peptides Services Market Share by Region (2020-2025)

Table 13. Global Pharmaceutical Peptides Services Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Pharmaceutical Peptides Services Market Share by Region (2026-2031)

Table 15. Pharmaceutical Peptides Services Market Trends

Table 16. Pharmaceutical Peptides Services Market Drivers

Table 17. Pharmaceutical Peptides Services Market Challenges

Table 18. Pharmaceutical Peptides Services Market Restraints

Table 19. Global Pharmaceutical Peptides Services Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Pharmaceutical Peptides Services Market Share by Players (2020-2025)

Table 21. Global Top Pharmaceutical Peptides Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Peptides Services as of 2024)

Table 22. Ranking of Global Top Pharmaceutical Peptides Services Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Pharmaceutical Peptides Services Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Pharmaceutical Peptides Services, Headquarters and Area Served

Table 25. Global Key Players of Pharmaceutical Peptides Services, Product and Application

Table 26. Global Key Players of Pharmaceutical Peptides Services, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Pharmaceutical Peptides Services Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Pharmaceutical Peptides Services Revenue Market Share by Type (2020-2025)

Table 30. Global Pharmaceutical Peptides Services Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Pharmaceutical Peptides Services Revenue Market Share by Type (2026-2031)

Table 32. Global Pharmaceutical Peptides Services Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Pharmaceutical Peptides Services Revenue Market Share by Application (2020-2025)

Table 34. Global Pharmaceutical Peptides Services Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Pharmaceutical Peptides Services Revenue Market Share by Application (2026-2031)

Table 36. North America Pharmaceutical Peptides Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Pharmaceutical Peptides Services Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Pharmaceutical Peptides Services Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Pharmaceutical Peptides Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Pharmaceutical Peptides Services Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Pharmaceutical Peptides Services Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Pharmaceutical Peptides Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Pharmaceutical Peptides Services Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Pharmaceutical Peptides Services Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Pharmaceutical Peptides Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Pharmaceutical Peptides Services Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Pharmaceutical Peptides Services Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Pharmaceutical Peptides Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Pharmaceutical Peptides Services Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Pharmaceutical Peptides Services Market Size by Country (2026-2031) & (US$ Million)

Table 51. Creative Peptides Company Details

Table 52. Creative Peptides Business Overview

Table 53. Creative Peptides Pharmaceutical Peptides Services Product

Table 54. Creative Peptides Revenue in Pharmaceutical Peptides Services Business (2020-2025) & (US$ Million)

Table 55. Creative Peptides Recent Development

Table 56. AmbioPharm Company Details

Table 57. AmbioPharm Business Overview

Table 58. AmbioPharm Pharmaceutical Peptides Services Product

Table 59. AmbioPharm Revenue in Pharmaceutical Peptides Services Business (2020-2025) & (US$ Million)

Table 60. AmbioPharm Recent Development

Table 61. 3B Pharmaceuticals Company Details

Table 62. 3B Pharmaceuticals Business Overview

Table 63. 3B Pharmaceuticals Pharmaceutical Peptides Services Product

Table 64. 3B Pharmaceuticals Revenue in Pharmaceutical Peptides Services Business (2020-2025) & (US$ Million)

Table 65. 3B Pharmaceuticals Recent Development

Table 66. ISSAR Pharma Company Details

Table 67. ISSAR Pharma Business Overview

Table 68. ISSAR Pharma Pharmaceutical Peptides Services Product

Table 69. ISSAR Pharma Revenue in Pharmaceutical Peptides Services Business (2020-2025) & (US$ Million)

Table 70. ISSAR Pharma Recent Development

Table 71. Peptide Institute Company Details

Table 72. Peptide Institute Business Overview

Table 73. Peptide Institute Pharmaceutical Peptides Services Product

Table 74. Peptide Institute Revenue in Pharmaceutical Peptides Services Business (2020-2025) & (US$ Million)

Table 75. Peptide Institute Recent Development

Table 76. WuXi AppTec Company Details

Table 77. WuXi AppTec Business Overview

Table 78. WuXi AppTec Pharmaceutical Peptides Services Product

Table 79. WuXi AppTec Revenue in Pharmaceutical Peptides Services Business (2020-2025) & (US$ Million)

Table 80. WuXi AppTec Recent Development

Table 81. JPT Peptide Technologies Company Details

Table 82. JPT Peptide Technologies Business Overview

Table 83. JPT Peptide Technologies Pharmaceutical Peptides Services Product

Table 84. JPT Peptide Technologies Revenue in Pharmaceutical Peptides Services Business (2020-2025) & (US$ Million)

Table 85. JPT Peptide Technologies Recent Development

Table 86. CPC Scientific Company Details

Table 87. CPC Scientific Business Overview

Table 88. CPC Scientific Pharmaceutical Peptides Services Product

Table 89. CPC Scientific Revenue in Pharmaceutical Peptides Services Business (2020-2025) & (US$ Million)

Table 90. CPC Scientific Recent Development

Table 91. Red Glead Discovery Company Details

Table 92. Red Glead Discovery Business Overview

Table 93. Red Glead Discovery Pharmaceutical Peptides Services Product

Table 94. Red Glead Discovery Revenue in Pharmaceutical Peptides Services Business (2020-2025) & (US$ Million)

Table 95. Red Glead Discovery Recent Development

Table 96. Eurofins Scientific Company Details

Table 97. Eurofins Scientific Business Overview

Table 98. Eurofins Scientific Pharmaceutical Peptides Services Product

Table 99. Eurofins Scientific Revenue in Pharmaceutical Peptides Services Business (2020-2025) & (US$ Million)

Table 100. Eurofins Scientific Recent Development

Table 101. Bio-Synthesis Company Details

Table 102. Bio-Synthesis Business Overview

Table 103. Bio-Synthesis Pharmaceutical Peptides Services Product

Table 104. Bio-Synthesis Revenue in Pharmaceutical Peptides Services Business (2020-2025) & (US$ Million)

Table 105. Bio-Synthesis Recent Development

Table 106. Bio Basic Company Details

Table 107. Bio Basic Business Overview

Table 108. Bio Basic Pharmaceutical Peptides Services Product

Table 109. Bio Basic Revenue in Pharmaceutical Peptides Services Business (2020-2025) & (US$ Million)

Table 110. Bio Basic Recent Development

Table 111. CordenPharma Company Details

Table 112. CordenPharma Business Overview

Table 113. CordenPharma Pharmaceutical Peptides Services Product

Table 114. CordenPharma Revenue in Pharmaceutical Peptides Services Business (2020-2025) & (US$ Million)

Table 115. CordenPharma Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

Table 119. Authors List of This Report

List of Figures

Figure 1. Pharmaceutical Peptides Services Picture

Figure 2. Global Pharmaceutical Peptides Services Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pharmaceutical Peptides Services Market Share by Type: 2024 VS 2031

Figure 4. Peptide Drug Discovery Features

Figure 5. Peptide Drug Bioconjugations Features

Figure 6. Peptide Lead Optimization Features

Figure 7. Formulation Development Features

Figure 8. Peptide Drug Screening Service Features

Figure 9. Total Peptide Library Construction Technology Features

Figure 10. Other Features

Figure 11. Global Pharmaceutical Peptides Services Market Size by Application (2020-2031) & (US$ Million)

Figure 12. Global Pharmaceutical Peptides Services Market Share by Application: 2024 VS 2031

Figure 13. Enterprise Case Studies

Figure 14. Research Institute Case Studies

Figure 15. Pharmaceutical Peptides Services Report Years Considered

Figure 16. Global Pharmaceutical Peptides Services Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Pharmaceutical Peptides Services Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Pharmaceutical Peptides Services Market Share by Region: 2024 VS 2031

Figure 19. Global Pharmaceutical Peptides Services Market Share by Players in 2024

Figure 20. Global Top Pharmaceutical Peptides Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Peptides Services as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Pharmaceutical Peptides Services Revenue in 2024

Figure 22. North America Pharmaceutical Peptides Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America Pharmaceutical Peptides Services Market Share by Country (2020-2031)

Figure 24. United States Pharmaceutical Peptides Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Pharmaceutical Peptides Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Pharmaceutical Peptides Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Pharmaceutical Peptides Services Market Share by Country (2020-2031)

Figure 28. Germany Pharmaceutical Peptides Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Pharmaceutical Peptides Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Pharmaceutical Peptides Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Pharmaceutical Peptides Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Pharmaceutical Peptides Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Pharmaceutical Peptides Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Pharmaceutical Peptides Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Pharmaceutical Peptides Services Market Share by Region (2020-2031)

Figure 36. China Pharmaceutical Peptides Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan Pharmaceutical Peptides Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea Pharmaceutical Peptides Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Pharmaceutical Peptides Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India Pharmaceutical Peptides Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia Pharmaceutical Peptides Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Pharmaceutical Peptides Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Pharmaceutical Peptides Services Market Share by Country (2020-2031)

Figure 44. Mexico Pharmaceutical Peptides Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil Pharmaceutical Peptides Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Pharmaceutical Peptides Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Pharmaceutical Peptides Services Market Share by Country (2020-2031)

Figure 48. Turkey Pharmaceutical Peptides Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Pharmaceutical Peptides Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE Pharmaceutical Peptides Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Creative Peptides Revenue Growth Rate in Pharmaceutical Peptides Services Business (2020-2025)

Figure 52. AmbioPharm Revenue Growth Rate in Pharmaceutical Peptides Services Business (2020-2025)

Figure 53. 3B Pharmaceuticals Revenue Growth Rate in Pharmaceutical Peptides Services Business (2020-2025)

Figure 54. ISSAR Pharma Revenue Growth Rate in Pharmaceutical Peptides Services Business (2020-2025)

Figure 55. Peptide Institute Revenue Growth Rate in Pharmaceutical Peptides Services Business (2020-2025)

Figure 56. WuXi AppTec Revenue Growth Rate in Pharmaceutical Peptides Services Business (2020-2025)

Figure 57. JPT Peptide Technologies Revenue Growth Rate in Pharmaceutical Peptides Services Business (2020-2025)

Figure 58. CPC Scientific Revenue Growth Rate in Pharmaceutical Peptides Services Business (2020-2025)

Figure 59. Red Glead Discovery Revenue Growth Rate in Pharmaceutical Peptides Services Business (2020-2025)

Figure 60. Eurofins Scientific Revenue Growth Rate in Pharmaceutical Peptides Services Business (2020-2025)

Figure 61. Bio-Synthesis Revenue Growth Rate in Pharmaceutical Peptides Services Business (2020-2025)

Figure 62. Bio Basic Revenue Growth Rate in Pharmaceutical Peptides Services Business (2020-2025)

Figure 63. CordenPharma Revenue Growth Rate in Pharmaceutical Peptides Services Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Multimode Microplate Readers Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-23X14667

Fri Feb 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Food and Pharmaceutical Inspection Systems Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-31A12370

Fri Feb 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global D-Lactate Assay Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-15E19102

Fri Feb 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Electrochemical Titrantors Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0X11283

Fri Feb 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions